semaglutide

The drug is prescribed for the treatment of inadequately controlled type 2 diabetes mellitus as an adjunct to diet and exercise. It can be used either as monotherapy or in combination with other medicinal products.

Form: solution for injection

ATC: A10BJ06

Manufacturer: A/S Novo Nordisk (manufacturing of product, filling of cartridges, and quality control of bulk products; chemical/physical testing, microbiological - sterility, and microbiological - microbial purity. Batch release)

The drug is intended for body weight management in adults with obesity or overweight (in the presence of comorbidities), as well as in children aged 12 years and older with obesity.

Form: solution for injection

ATC: A10BJ06

Manufacturer: A/S Novo Nordisk (preparation, filling, and quality control of bulk products (1.5 mL and 3 mL cartridges). Responsible for batch release of the finished medicinal product; preparation, filling, and quality control of bulk products (1.5 mL and 3 mL cartridges). Assembly, labeling, and packaging of the finished medicinal product (semaglutide, solution for injection, 1.5 mL and 3 mL, pre-filled pen PDS290 for semaglutide))

The drug is intended for body weight management in adults (for obesity or overweight with comorbidities) and children aged 12 years and older (for obesity and weight over 60 kg) as an adjunct to a reduced-calorie diet and increased physical activity.

Form: solution for injection

ATC: A10BJ06

Manufacturer: A/S Novo Nordisk (preparation, filling, and quality control of bulk products (1.5 mL and 3 mL cartridges). Responsible for batch release of the finished medicinal product; preparation, filling, and quality control of bulk products (1.5 mL and 3 mL cartridges). Assembly, labeling, and packaging of the finished medicinal product (semaglutide, solution for injection, 1.5 mL and 3 mL, pre-filled pen PDS290 for semaglutide))

The drug is intended for body weight management as an adjunct to a reduced-calorie diet and increased physical activity. It is used by adults with obesity or overweight (in the presence of comorbidities), as well as children aged 12 years and older with obesity.

Form: solution for injection

ATC: A10BJ06

Manufacturer: A/S Novo Nordisk (preparation, filling, and quality control of bulk products (1.5 mL and 3 mL cartridges). Responsible for batch release of the finished medicinal product; preparation, filling, and quality control of bulk products (1.5 mL and 3 mL cartridges). Assembly, labeling, and packaging of the finished medicinal product (semaglutide, solution for injection, 1.5 mL and 3 mL, pre-filled pen PDS290 for semaglutide))

The drug is intended for body weight management in adults with obesity or overweight (in the presence of comorbidities), as well as in children aged 12 years and older with obesity.

Form: solution for injection

ATC: A10BJ06

Manufacturer: A/S Novo Nordisk (preparation, filling, and quality control of bulk products (1.5 mL and 3 mL cartridges). Responsible for batch release of the finished medicinal product; preparation, filling, and quality control of bulk products (1.5 mL and 3 mL cartridges). Assembly, labeling, and packaging of the finished medicinal product (semaglutide, solution for injection, 1.5 mL and 3 mL, pre-filled pen PDS290 for semaglutide))

The drug is intended for body weight management in adults and children aged 12 years and older with obesity or overweight (in the presence of weight-related comorbidities).

Form: solution for injection

ATC: A10BJ06

Manufacturer: A/S Novo Nordisk (preparation, filling, and quality control of bulk products (1.5 mL and 3 mL cartridges). Responsible for batch release of the finished medicinal product; preparation, filling, and quality control of bulk products (1.5 mL and 3 mL cartridges). Assembly, labeling, and packaging of the finished medicinal product (semaglutide, solution for injection, 1.5 mL and 3 mL, pre-filled pen PDS290 for semaglutide))